"There are plenty of pharma companies headquartere
Post# of 148288
Additionally, BMY has a very strong oncology department. Opdivo isn't giving as strong a return as they had hoped. Ketruda (Merck) has taken a chunk of the market share from them.
Read More: https://investorshangout.com/post/newpost/605...z7KXzM6juS